Friedman A - Search Results

1

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A. Jost WH, et al. Among authors: friedman a. Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918101 Free PMC article. Clinical Trial.

2

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE, et al. Brin MF, et al. Among authors: friedman a. Adv Neurol. 1988;50:599-608. Adv Neurol. 1988. PMID: 3400513 No abstract available.

3

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE, et al. Brin MF, et al. Among authors: friedman a. Mov Disord. 1987;2(4):237-54. doi: 10.1002/mds.870020402. Mov Disord. 1987. PMID: 3504553

4

[Consensus regarding indications for surgical treatment of Parkinson disease].

Friedman A, Harat M, Opala G, Sławek J, Zabek M. Friedman A, et al. Neurol Neurochir Pol. 2003;37 Suppl 5:11-7. Neurol Neurochir Pol. 2003. PMID: 15098326 Polish.

5

[Dopa-responsive dystonia (Segawa variant): clinical analysis of 7 cases with delayed diagnosis].

Sławek J, Friedman A, Bogucki A, Budrewicz S, Banach M. Sławek J, et al. Among authors: friedman a. Neurol Neurochir Pol. 2003;37 Suppl 5:117-26. Neurol Neurochir Pol. 2003. PMID: 15098338 Polish.

6

Quality of life in Polish patients with long-lasting Parkinson's disease.

Zach M, Friedman A, Sławek J, Derejko M. Zach M, et al. Among authors: friedman a. Mov Disord. 2004 Jun;19(6):667-72. doi: 10.1002/mds.10698. Mov Disord. 2004. PMID: 15197705

7

[Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].

Sławek J, Bogucki A, Banach M, Członkowska A, Friedman A, Krawczyk M, Kwolek A, Opara J, Ochudło S, Zaborski J. Sławek J, et al. Among authors: friedman a. Neurol Neurochir Pol. 2004 Nov-Dec;38(6):443-5. Neurol Neurochir Pol. 2004. PMID: 15654667 Polish. No abstract available.

8

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G. Slawek J, et al. Among authors: friedman a. Funct Neurol. 2007 Apr-Jun;22(2):95-100. Funct Neurol. 2007. PMID: 17637212

9

Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.

Koziorowski D, Hoffman-Zacharska D, Sławek J, Szirkowiec W, Janik P, Bal J, Friedman A. Koziorowski D, et al. Among authors: friedman a. Parkinsonism Relat Disord. 2010 Feb;16(2):136-8. doi: 10.1016/j.parkreldis.2009.06.010. Epub 2009 Jul 22. Parkinsonism Relat Disord. 2010. PMID: 19628420

10

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Dorsch U, Csikós J, Blitzer A. Jost WH, et al. Among authors: friedman a. Parkinsonism Relat Disord. 2020 Jan;70:23-30. doi: 10.1016/j.parkreldis.2019.11.024. Epub 2019 Nov 26. Parkinsonism Relat Disord. 2020. PMID: 31794936 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,840 results

Search Page

Filters